Phaseline

Targets › LINUP

LINUP: drug programs, companies and trials

1 program from 1 company in 3 trials: 2 Phase 2, 1 Phase 1; Infectious disease; next expected readout Feb 2027.

Open in Phaseline: the race on LINUP, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
SanariaPfSPZ-LARC2 Vaccine
Double deletion of MEI2 and LINUP genes in Plasmodium falciparum NF54 sporozoites - arrest
LINUP, MEI2Phase 2Malaria (Plasmodium Falciparum); Malaria FalciparumFeb 2027

Conditions

Malaria (Plasmodium Falciparum) (2) Malaria Falciparum (1)

Modalities

mixed (1)

Companies

Sanaria (1)

Related targets

MEI2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.